Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Long-Term Deferred Tax: 2019-2020

Historic Long-Term Deferred Tax for Silence Therapeutics (SLN) over the last 2 years, with Dec 2020 value amounting to $32,104.

  • Silence Therapeutics' Long-Term Deferred Tax rose 6.98% to $33,011 in Q4 2020 from the same period last year, while for Dec 2020 it was $33,011, marking a year-over-year increase of 6.98%. This contributed to the annual value of $32,104 for FY2020, which is 4.76% up from last year.
  • Silence Therapeutics' Long-Term Deferred Tax amounted to $32,104 in FY2020, which was up 4.76% from $30,644 recorded in FY2019.
  • Over the past 5 years, Silence Therapeutics' Long-Term Deferred Tax peaked at $32,104 during FY2020, and registered a low of $30,644 during FY2019.
  • Over the past 2 years, Silence Therapeutics' median Long-Term Deferred Tax value was $31,374 (recorded in 2019), while the average stood at $31,374.
  • Data for Silence Therapeutics' Long-Term Deferred Tax shows a peak YoY climbed of 4.76% (in 2020) over the last 5 years.
  • Silence Therapeutics' Long-Term Deferred Tax (Yearly) stood at $30,644 in 2019, then climbed by 4.76% to $32,104 in 2020.